Search

everythinglearnresearchcommunity

for

Search:↓

Low serum ferritin levels are linked to hair loss in women.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

The document concludes that the FOLLYSIS© system improves hair transplant processes and patient monitoring with high accuracy and less skin trauma.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Avoiding salicylates improved skin issues and stabilized hair loss in a woman with frontal fibrosing alopecia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Higher FABP4 levels may indicate more severe alopecia areata.

Common fennel fruits can be effectively used to make medicines for better digestion.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Researchers should follow the FACE-Q User's Guide for accurate results.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.